Evidence map›Paper›PMID 41835554›Full record

ArticleACS omega2026

Cytotoxic Agents by the Phosphinoylation and Thiophosphinoylation of 3‑Hydroxy-1,2,3,6-tetrahydrophosphinine 1‑Oxides as β‑Hydroxyphosphonates and -Phosphine Oxides.

Zsuzsanna Szalai, Kristóf Szloboda, Konstantin Karaghiosoff, Mátyás Czugler, Angéla Takács, László Kőhidai, Ágnes Gömöry, László Drahos, György Keglevich

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Zsuzsanna SzalaiDepartment of Organic Chemistry and Technology, Faculty of Chemical Technology and Biotechnology, Budapest University of Technology and Economics, Műegyetem rkp. 3, 1111 Budapest, Hungary.
Kristóf SzlobodaDepartment of Organic Chemistry and Technology, Faculty of Chemical Technology and Biotechnology, Budapest University of Technology and Economics, Műegyetem rkp. 3, 1111 Budapest, Hungary.
Konstantin KaraghiosoffDepartment Chemie, Ludwig-Maximilians-Universität München, Butenandtstr. 5-13, D-81377 München, Germany.ORCID https://orcid.org/0000-0002-8855-730X
Mátyás CzuglerDepartment of Organic Chemistry and Technology, Faculty of Chemical Technology and Biotechnology, Budapest University of Technology and Economics, Műegyetem rkp. 3, 1111 Budapest, Hungary.
Angéla TakácsDepartment of Genetics, Cell and Immunobiology, Semmelweis University, Nagyvárad tér 4, 1089 Budapest, Hungary.
László KőhidaiDepartment of Genetics, Cell and Immunobiology, Semmelweis University, Nagyvárad tér 4, 1089 Budapest, Hungary.
Ágnes GömöryMS Proteomics Research Group, Research Centre for Natural Sciences, 1117 Budapest, Hungary.
László DrahosMS Proteomics Research Group, Research Centre for Natural Sciences, 1117 Budapest, Hungary.ORCID https://orcid.org/0000-0001-9589-6652
György KeglevichDepartment of Organic Chemistry and Technology, Faculty of Chemical Technology and Biotechnology, Budapest University of Technology and Economics, Műegyetem rkp. 3, 1111 Budapest, Hungary.ORCID https://orcid.org/0000-0002-5366-472X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A series of hydroxy-1,2,3,6-tetrahydrophosphinine oxides were prepared by the two-step ring enlargement of 1-substituted 3-phospholene 1-oxides via the corresponding dichlorocarbene adducts. The two diastereomers of the

Identifiers

PMID41835554
PMCPMC12980232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.